Company Information

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.

Stock Information

As of

View Stock Information

Upcoming Events

Piper Jaffray 26th Annual healthcare Conference

Dec 2 2014 - Dec 3 2014 • New York, NY

ISI MedTools Conference

Dec 3 2014 - Dec 4 2014 • Boston, MA

American Society of Hematology Annual Meeting

Dec 6 2014 - Dec 9 2014 • San Francisco, CA

Recent News



Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070

Investor Relations

Life Science Advisors LLC
Michael Rice